retatrutide clinical trials phase 3 First data for are here folks. This drug is a barn burner. This was only 68 weeks and was geared towards osteoarthritis of the knee. Massive pain improvements and Retatrutide, an investigational triple hormone

So, grab your popcorn, put on your 3D glasses, and let's dive into the glitzy world of weight loss drugs

Some companies are beginning to cover for other conditions, including obesity, heart disease, obesity with sleep apnea or obesity with high blood pressure

Sjgrens syndrome SS is a chronic autoimmune disorder that predominantly impacts the exocrine glandular system, particularly the lacrimal and salivary glands

u003ca href=u0022#Common-GLP-1-Side-Effectsu0022u003eGLP-1 side effects usually start early in treatmentu003c/au003e

For patients primarily seeking weight management, either with or without type 2 diabetes, higher-dose formulations such as semaglutide 2.4 mg (Wegovy) or liraglutide 3 mg (Saxenda) may be more appropriate

Patients deserve better When it comes to obesity and these revolutionary new drugs (GLP1s+), we have to hold two competing ideas simultaneously